Literature DB >> 16461979

Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia.

Anton I Skaro, Paul J Marotta, Vivian C McAlister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16461979     DOI： 10.7326/0003-4819-144-3-200602070-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  Hereditary hemorrhagic telangiectasia of the liver complicated by ischemic bile duct necrosis and sepsis: case report and review of the literature.

Authors:  Anastasios Mavrakis; Anthony Demetris; Erin Rubin Ochoa; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2009-09-16       Impact factor: 3.199

Review 2.  Advances in the Medical Management of Vascular Anomalies.

Authors:  Kiersten W Ricci
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

3.  [Diagnosis and treatment of Osler's disease].

Authors:  F Haubner; T Kühnel
Journal:  HNO       Date:  2018-05       Impact factor: 1.284

4.  Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.

Authors:  Santiago Ruiz; Haitian Zhao; Pallavi Chandakkar; Julien Papoin; Hyunwoo Choi; Aya Nomura-Kitabayashi; Radhika Patel; Matthew Gillen; Li Diao; Prodyot K Chatterjee; Mingzhu He; Yousef Al-Abed; Ping Wang; Christine N Metz; S Paul Oh; Lionel Blanc; Fabien Campagne; Philippe Marambaud
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

5.  Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.

Authors:  Santiago Ruiz; Pallavi Chandakkar; Haitian Zhao; Julien Papoin; Prodyot K Chatterjee; Erica Christen; Christine N Metz; Lionel Blanc; Fabien Campagne; Philippe Marambaud
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

Review 6.  Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Authors:  Daniela S Ardelean; Michelle Letarte
Journal:  Front Genet       Date:  2015-02-11       Impact factor: 4.599

Review 7.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

8.  PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.

Authors:  Adriana Iriarte; Agnes Figueras; Pau Cerdà; José María Mora; Anna Jucglà; Rosa Penín; Francesc Viñals; Antoni Riera-Mestre
Journal:  Cells       Date:  2019-08-24       Impact factor: 6.600

Review 9.  Future treatments for hereditary hemorrhagic telangiectasia.

Authors:  Florian Robert; Agnès Desroches-Castan; Sabine Bailly; Sophie Dupuis-Girod; Jean-Jacques Feige
Journal:  Orphanet J Rare Dis       Date:  2020-01-07       Impact factor: 4.123

10.  Diagnostic yield of capsule endoscopy for small bowel arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.

Authors:  Kevin Singh; Ayla Zubair; Andrew Prindle; Ahmed Jamal Nadeem; Gulam Khan
Journal:  Endosc Int Open       Date:  2019-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.